公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3) | Okada M.; Kato K.; Cho B.C.; Takahashi M.; Lin C.-Y.; Chin K.; Kadowaki S.; Ahn M.-J.; Hamamoto Y.; Doki Y.; Yen C.-C.; Kubota Y.; Kim S.-B.; CHIH-HUNG HSU ; Holtved E.; Xynos I.; Matsumura Y.; Takazawa A.; Kitagawa Y. | Clinical Cancer Research | 18 | 16 | |
2002 | Tissue distribution of different mercurial compounds analyzed by the improved FI-CVAAS | Yen C.-C.; SHING-HWA LIU ; Chen W.-K.; Lin R.-H.; Lin-Shiau S.-Y. | Journal of Analytical Toxicology | 27 | 25 | |
2012 | Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer | Yeh C.-T.; Wu T.-H.; Chang P.M.-H.; KUAN-YU CHEN ; Yang C.-N.; Yang S.-C.; CHAO-CHI HO ; Chen C.-C.; Kuo Y.-L.; Lee P.-Y.; Liu Y.-W.; Yen C.-C.; Hsiao M.; Lu P.-J.; Lai J.-M.; Wang L.-S.; Wu C.-H.; Chiou J.-F.; PAN-CHYR YANG ; Huang C.-Y.F. | American Journal of Respiratory and Critical Care Medicine | 163 | 150 |